(Q38206826)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762115%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

title

Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762115%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762115%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

author name string

Srinivas Reddy Boreddy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762115%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Amit Singh

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762115%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Mansoor Amiji

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762115%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

language of work or name

English

0 references

publication date

25 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762115%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

15 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762115%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762115%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762115%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

page(s)

1145-1159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762115%20AND%20SRC:MED&resulttype=core&format=json

Aerobic glycolysis: meeting the metabolic requirements of cell proliferation

15 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Cancer's craving for sugar: an opportunity for clinical exploitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

The impact of O2 availability on human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Glycolysis in cancer: a potential target for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Acid-mediated tumor invasion: a multidisciplinary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Targeting hypoxia in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

The updated biology of hypoxia-inducible factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Hypoxia inducible factors in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

The role of hypoxia-inducible factors in tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Hypoxia-induced angiogenesis: good and evil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Development of HIF-1 inhibitors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Ras transformation requires metabolic control by 6-phosphofructo-2-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Evidence for an alternative glycolytic pathway in rapidly proliferating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Regulation of pyruvate kinase M gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

The interplay between MYC and HIF in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Tumor cell metabolism: cancer's Achilles' heel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Tirapazamine: a novel agent targeting hypoxic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

MicroRNAs in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Phloretin-induced apoptosis in B16 melanoma 4A5 cells and HL60 human leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Therapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Ascorbic acid and a cytostatic inhibitor of glycolysis synergistically induce apoptosis in non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Identification of small molecule inhibitors of pyruvate kinase M2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Small Molecule Activation of PKM2 in Cancer Cells Induces Serine Auxotrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Antimetastatic effect of a small-molecule vacuolar H+-ATPase inhibitor in in vitro and in vivo preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Human tumor extracellular pH as a function of blood glucose concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

2,4-dinitrophenol induces G1 phase arrest and apoptosis in human pulmonary adenocarcinoma Calu-6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Tissue-penetrating delivery of compounds and nanoparticles into tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

The promise of microRNA replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Metabolic pathway alterations that support cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270

Exploiting tumour hypoxia in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.912270